From: Association of chorioretinal thickness with chronic kidney disease
RNFL | CKD stages | F | P | ||
---|---|---|---|---|---|
Stage 1–2 (n = 22) | Stage 3 (n = 38) | Stage 4–5 (n = 84) | |||
Nasal | |||||
Min. – Max. | 63.0–116.0 | 49.0–93.0 | 49.0–131.0 | 2.850 | 0.061 |
Mean ± SD. | 81.64 ± 13.35 | 72.45 ± 10.04 | 78.10 ± 17.74 | ||
Median (IQR) | 80.50 (73.0–85.0) | 73.0 (66.0–78.0) | 70.0 (65.50–89.0) | ||
Superior | |||||
Min. – Max. | 110.0–168.0 | 110.0–159.0 | 102.0–180.0 | 0.155 | 0.857 |
Mean ± SD. | 128.32 ± 14.62 | 127.58 ± 10.81 | 126.56 ± 15.98 | ||
Median (IQR) | 123.5 (117.0–135.0) | 127.0 (118.0–138.0) | 123.0 (116.0–133.5) | ||
Temporal | |||||
Min. – Max. | 63.0–100.0 | 50.0–104.0 | 49.0–176.0 | 1.610 | 0.204 |
Mean ± SD. | 76.86 ± 11.54 | 76.0 ± 13.18 | 82.20 ± 23.11 | ||
Median (IQR) | 76.0 (66.0–84.0) | 73.50 (67.0–85.0) | 78.0 (66.0–91.0) | ||
Inferior | |||||
Min. – Max. | 112.0–148.0 | 95.0–141.0 | 64.0–168.0 | 2.445 | 0.090 |
Mean ± SD. | 128.45 ± 9.80 | 123.61 ± 10.53 | 121.26 ± 15.71 | ||
Median (IQR) | 125.0 (122.0–137.0) | 124.50 (118.0–132.0) | 121.0 (112.5–128.0) |